Md Nahid Hasan

h-index9
2papers
222citations

2 Papers

3.6CVDec 2, 2025
GraphFusion3D: Dynamic Graph Attention Convolution with Adaptive Cross-Modal Transformer for 3D Object Detection

Md Sohag Mia, Md Nahid Hasan, Tawhid Ahmed et al.

Despite significant progress in 3D object detection, point clouds remain challenging due to sparse data, incomplete structures, and limited semantic information. Capturing contextual relationships between distant objects presents additional difficulties. To address these challenges, we propose GraphFusion3D, a unified framework combining multi-modal fusion with advanced feature learning. Our approach introduces the Adaptive Cross-Modal Transformer (ACMT), which adaptively integrates image features into point representations to enrich both geometric and semantic information. For proposal refinement, we introduce the Graph Reasoning Module (GRM), a novel mechanism that models neighborhood relationships to simultaneously capture local geometric structures and global semantic context. The module employs multi-scale graph attention to dynamically weight both spatial proximity and feature similarity between proposals. We further employ a cascade decoder that progressively refines detections through multi-stage predictions. Extensive experiments on SUN RGB-D (70.6\% AP$_{25}$ and 51.2\% AP$_{50}$) and ScanNetV2 (75.1\% AP$_{25}$ and 60.8\% AP$_{50}$) demonstrate a substantial performance improvement over existing approaches.

1.2APJun 23, 2025
A Machine Learning Framework for Breast Cancer Treatment Classification Using a Novel Dataset

Md Nahid Hasan, Md Monzur Murshed, Md Mahadi Hasan et al.

Breast cancer (BC) remains a significant global health challenge, with personalized treatment selection complicated by the disease's molecular and clinical heterogeneity. BC treatment decisions rely on various patient-specific clinical factors, and machine learning (ML) offers a powerful approach to predicting treatment outcomes. This study utilizes The Cancer Genome Atlas (TCGA) breast cancer clinical dataset to develop ML models for predicting the likelihood of undergoing chemotherapy or hormonal therapy. The models are trained using five-fold cross-validation and evaluated through performance metrics, including accuracy, precision, recall, specificity, sensitivity, F1-score, and area under the receiver operating characteristic curve (AUROC). Model uncertainty is assessed using bootstrap techniques, while SHAP values enhance interpretability by identifying key predictors. Among the tested models, the Gradient Boosting Machine (GBM) achieves the highest stable performance (accuracy = 0.7718, AUROC = 0.8252), followed by Extreme Gradient Boosting (XGBoost) (accuracy = 0.7557, AUROC = 0.8044) and Adaptive Boosting (AdaBoost) (accuracy = 0.7552, AUROC = 0.8016). These findings underscore the potential of ML in supporting personalized breast cancer treatment decisions through data-driven insights.